| 1 |
34882770 | Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS). | 2021 Nov 19 |
2 |
| 2 |
30535366 | Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites. | 2019 Mar 1 |
1 |
| 3 |
26288843 | Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis. | 2015 Jul |
2 |
| 4 |
24316028 | The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients. | 2014 Feb |
1 |
| 5 |
24820076 | Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6. | 2014 Jul |
1 |
| 6 |
19371316 | CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients. | 2009 Apr |
1 |